Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$890.11 6.23 (0.7%) as of 4:30 Mon 6/24


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 851.46(B)
Last Volume: 2,877,071 Avg Vol: 3,271,395
52 Week Range: $434.7 - $891.46
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,332,477 2,203,227 3,639,104 6,172,895
Total Sell Value $1,114,649,593 $1,722,900,173 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 17 30 51 94
End Date 2024-03-26 2023-12-24 2023-06-25 2022-06-25

   
Records found: 1436
  Page 30 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Alvarez Ralph Director   –       •      –    2019-02-19 4 A $122.13 $10,870 D/D 89 43,462     -
   Norton Johna Senior VP, Global Quality   •       –      –    2019-02-16 4 D $122.48 $2,082 I/I (17) 65     -
   Norton Johna Senior VP, Global Quality   •       –      –    2019-02-16 4 OE $0.00 $0 I/I 48 82     -
   Conterno Enrique A SVP&Pres, LillyDiab & LillyUSA   •       –      –    2019-02-15 4 AS $121.00 $3,025,000 D/D (25,000) 132,962     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2019-02-11 4 GA $0.00 $0 I/I 62,500 62,500     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2019-02-11 4 GD $0.00 $0 D/D 62,500 47,800     -
   Conterno Enrique A SVP&Pres, LillyDiab & LillyUSA   •       –      –    2019-02-04 4/A A $120.17 $3,206,376 D/D 26,682 157,962     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2019-02-04 4/A A $120.17 $389,952 D/D 3,245 6,595     -
   Smiley Joshua L SVP and CFO   •       –      –    2019-02-04 4/A A $120.17 $1,196,292 D/D 9,955 29,984     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2019-02-04 4/A A $120.17 $1,032,621 D/D 8,593 40,646     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2019-02-04 4/A A $120.17 $563,597 I/I 4,690 57,374     -
   Shah Aarti S. SVP & CIO   •       –      –    2019-02-04 4/A A $120.17 $713,810 D/D 5,940 20,225     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2019-02-04 4/A A $120.17 $3,383,507 D/D 28,156 126,300     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2019-02-04 4/A A $120.17 $2,331,899 D/D 19,405 124,510     -
   Norton Johna Senior VP, Global Quality   •       –      –    2019-02-04 4/A A $120.17 $355,703 D/D 2,960 20,819     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2019-02-04 4 A $120.17 $389,711 D/D 3,243 6,593     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2019-02-04 4 A $120.17 $1,032,501 D/D 8,592 40,645     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2019-02-04 4 A $120.17 $556,988 I/I 4,635 57,319     -
   Smiley Joshua L SVP and CFO   •       –      –    2019-02-04 4 A $120.17 $1,196,172 D/D 9,954 29,983     -
   Ricks David A President & CEO   •       •      –    2019-02-04 4 A $120.17 $3,192,556 D/D 26,567 152,790     -
   White Anne E. SVP & Pres-Lilly Oncology   •       –      –    2019-02-04 4 A $120.17 $870,752 D/D 7,246 21,043     -
   Skovronsky Daniel SVP, CSO, and Pres. LRL   •       –      –    2019-02-04 4 A $120.17 $1,876,935 D/D 15,619 70,818     -
   Zulueta Alfonso G SVP & President, Lilly Intl   •       –      –    2019-02-04 4 A $120.17 $2,550,488 D/D 21,224 67,806     -
   Shah Aarti S. SVP & CIO   •       –      –    2019-02-04 4 A $120.17 $713,690 D/D 5,939 20,224     -
   Conterno Enrique A SVP&Pres, LillyDiab & LillyUSA   •       –      –    2019-02-04 4 A $120.17 $3,206,256 D/D 26,681 157,961     -
  1436 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 30 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us